Molecular Basis of Coats Plus Disease
Coats Plus 疾病的分子基础
基本信息
- 批准号:10797782
- 负责人:
- 金额:$ 4.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The Coats plus syndrome is a rare and life-threatening genetic disorder characterized by multi-system
developmental defects that lead to bilateral exudative retinopathy, retinal telangiectasias, growth retardation,
intracranial calcifications, bone abnormalities, gastrointestinal vascular ectasias, and common early-aging
pathological features. Like many other developmental disorders, Coats plus is caused by defects in genes
involved in maintaining global genome integrity. Specifically, it is caused by loss-of-function mutations in the
human CTC1/STN1/TEN1 (CST) complex, which is a trimeric complex that preferentially binds to G-rich ssDNA
or ss-ds DNA junctions and is critical for preventing genome instabilities arising from replication perturbation. We
hope to aid in better understanding of disease development and designing of effective therapeutic strategies by
investigating the mechanisms governing genome stability under replication stress. In response to fork stalling,
signaling cascades activate multiple pathways including fork reversal, translesion synthesis, repriming
downstream of stalled sites, and dormant origin firing to rescue stalled replication. Activities of these pathways
need to be tightly regulated to ensure replication fidelity. The objectives of this proposal is to delineate a novel
signaling pathway in response to replication stress, elucidate how it regulates protein interplays and recruitment
at stalled forks, and understand the mechanism regulating the repriming pathway. In Aim 1, we hypothesize that
a calcium-dependent signaling pathway phosphorylates STN1 to activate CST at stalled forks to protect the
stability of stalled forks. We will elucidate this new signaling pathway and determine how this pathway
antagonizes unscheduled nascent strand DNA degradation and regulates fork protection. In Aim 2, we will
investigate how this signaling pathway regulates the interplay of single-strand DNA binding proteins at forks and
other fork binding proteins. In Aim 3, we will investigate the mechanism for restricting excessive repriming to
prevent ssDNA gap formation and genome instability. We will combine highly sensitive cell-based analyses,
single-molecule and powerful biochemical assays to accomplish the goals of the proposed research. We expect
that our efforts will identify new factors and pathways regulating the rescue of stalled replication and the
preservation of genome stability.
大衣加综合征是一种罕见且威胁生命的遗传疾病,其特征是多系统
发育缺陷导致双侧渗出性视网膜病,视网膜毛细血管扩张,生长迟钝,
颅内钙化,骨异常,胃肠道血管临界和常见的早期衰老
病理特征。像许多其他发育障碍一样,大衣加也是由基因缺陷引起的
参与维持全球基因组完整性。具体而言,它是由功能丧失突变引起的
人CTC1/STN1/TEN1(CST)配合物,它是一种三聚体配合物,优先结合G-富含G的ssDNA
或SS-DS DNA连接,对于预防复制扰动引起的基因组不稳定性至关重要。我们
希望通过
研究在复制应力下控制基因组稳定性的机制。为了响应叉子拖延,
信号传导级联激活多种途径,包括叉反转,translesion合成,谴责
停滞地点的下游和休眠的起源射击以挽救停滞的复制。这些途径的活动
需要严格调节以确保复制保真度。该提议的目标是描绘一本小说
响应复制应力的信号通路,阐明其如何调节蛋白质相互作用和募集
在失速的叉子上,了解调节谴责途径的机制。在AIM 1中,我们假设
依赖钙的信号通路磷酸化STN1在失速叉处激活CST以保护
失速叉的稳定性。我们将阐明这种新的信号通路,并确定该途径如何
拮抗外生的新生链DNA降解并调节叉子保护。在AIM 2中,我们将
研究该信号通路如何调节分叉和
其他叉子结合蛋白。在AIM 3中,我们将调查限制过度谴责的机制
预防ssDNA间隙形成和基因组不稳定性。我们将结合高度敏感的基于细胞的分析,
单分子和强大的生化测定法以实现拟议研究的目标。我们期望
我们的努力将确定规范停滞复制的新因素和途径
保存基因组稳定性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Weihang Chai的其他基金
Molecular Basis of Coats Plus Disease
Coats Plus 疾病的分子基础
- 批准号:1060712610607126
- 财政年份:2023
- 资助金额:$ 4.51万$ 4.51万
- 项目类别:
Identification of a novel tumor suppressorof melanoma and UV-induced genome instability
黑色素瘤的新型肿瘤抑制因子和紫外线诱导的基因组不稳定性的鉴定
- 批准号:1053956110539561
- 财政年份:2022
- 资助金额:$ 4.51万$ 4.51万
- 项目类别:
Role of Telomerase is DSB Repair
端粒酶的作用是 DSB 修复
- 批准号:1005295310052953
- 财政年份:2019
- 资助金额:$ 4.51万$ 4.51万
- 项目类别:
Molecular Modulator of RPA and RAD51 in Maintaining Genome Stability
RPA 和 RAD51 维持基因组稳定性的分子调节剂
- 批准号:1015372910153729
- 财政年份:2019
- 资助金额:$ 4.51万$ 4.51万
- 项目类别:
Molecular Modulator of RPA and RAD51 in Maintaining Genome Stability
RPA 和 RAD51 维持基因组稳定性的分子调节剂
- 批准号:1005586010055860
- 财政年份:2019
- 资助金额:$ 4.51万$ 4.51万
- 项目类别:
Molecular Modulator of RPA and RAD51 in Maintaining Genome Stability
RPA 和 RAD51 维持基因组稳定性的分子调节剂
- 批准号:1032274210322742
- 财政年份:2019
- 资助金额:$ 4.51万$ 4.51万
- 项目类别:
Molecular Modulator of RPA and RAD51 in Maintaining Genome Stability
RPA 和 RAD51 维持基因组稳定性的分子调节剂
- 批准号:1054120110541201
- 财政年份:2019
- 资助金额:$ 4.51万$ 4.51万
- 项目类别:
Role of human CST in preventing telomere loss
人类 CST 在预防端粒丢失中的作用
- 批准号:91454379145437
- 财政年份:2015
- 资助金额:$ 4.51万$ 4.51万
- 项目类别:
Mechanisms of fork restart in response to genotoxic stress
响应基因毒性应激的分叉重启机制
- 批准号:88002478800247
- 财政年份:2014
- 资助金额:$ 4.51万$ 4.51万
- 项目类别:
Mechanisms of fork restart in response to genotoxic stress
响应基因毒性应激的分叉重启机制
- 批准号:95516369551636
- 财政年份:2014
- 资助金额:$ 4.51万$ 4.51万
- 项目类别:
相似国自然基金
α-突触核蛋白与脂肪酸结合蛋白FABP3相互作用维持自身低聚体形态的机制研究
- 批准号:82301632
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
脂肪酸结合蛋白4(FABP4)调控肾小管上皮细胞铁死亡在移植肾功能延迟恢复 (DGF)中的机制研究
- 批准号:82360154
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
O-糖链芯片构建新方法及受体蛋白结合O-糖链的筛选与制备
- 批准号:32371342
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
双链RNA结合蛋白协同调控水稻株型与抗逆性的耦合机制及育种利用
- 批准号:32372125
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
低磷诱导钙调素结合蛋白RAPS1泛素化降解和调控根际酸化的分子机制
- 批准号:32370283
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Molecular Basis of Coats Plus Disease
Coats Plus 疾病的分子基础
- 批准号:1060712610607126
- 财政年份:2023
- 资助金额:$ 4.51万$ 4.51万
- 项目类别:
The role of extracellular vesicles in keratoconus pathogenesis
细胞外囊泡在圆锥角膜发病机制中的作用
- 批准号:1059512110595121
- 财政年份:2023
- 资助金额:$ 4.51万$ 4.51万
- 项目类别:
Targeting immune dysfunction during transition from AKI to CKD
针对 AKI 向 CKD 过渡期间的免疫功能障碍
- 批准号:1063618910636189
- 财政年份:2023
- 资助金额:$ 4.51万$ 4.51万
- 项目类别:
Investigating the role and therapeutic potential of the alpha5beta1 integrin in risk factors for COVID-19-associated cognitive impairment
研究 α5β1 整合素在 COVID-19 相关认知障碍危险因素中的作用和治疗潜力
- 批准号:1065817810658178
- 财政年份:2023
- 资助金额:$ 4.51万$ 4.51万
- 项目类别:
Vulnerability Profiles of Comorbid Alzheimer and TDP-43 Proteinopathies in Amnestic Dementia
遗忘性痴呆中共病阿尔茨海默病和 TDP-43 蛋白病的脆弱性概况
- 批准号:1090101010901010
- 财政年份:2023
- 资助金额:$ 4.51万$ 4.51万
- 项目类别: